These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6738365)

  • 1. Relationships between squalene and cholesterol in bile: effect of ursodeoxycholic acid administration in patients with radiolucent gallstones.
    Salvioli G; Lugli R; Pradelli JM
    Metabolism; 1984 Jul; 33(7):641-5. PubMed ID: 6738365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ursodeoxycholic acid treatment in humans: effects on plasma and biliary lipid metabolism with special reference to very low density lipoprotein triglyceride and bile acid kinetics.
    Angelin B; Nilsell K; Einarsson K
    Eur J Clin Invest; 1986 Apr; 16(2):169-77. PubMed ID: 3089812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ursodeoxycholic acid treatment in cholesterol gallstone disease: effects on hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity, biliary lipid composition, and plasma lipid levels.
    Angelin B; Ewerth S; Einarsson K
    J Lipid Res; 1983 Apr; 24(4):461-8. PubMed ID: 6854153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of litholytic bile acids on cholesterol absorption in gallstone patients.
    LaRusso NF; Thistle JL
    Gastroenterology; 1983 Feb; 84(2):265-71. PubMed ID: 6848406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differing effects of ursodeoxycholic or chenodeoxycholic acid on biliary cholesterol saturation and bile acid metabolism in man. A dose-response study.
    Thistle JL; Larusso NF; Hofmann AF; Turcotte J; Carlson GL; Ott BJ
    Dig Dis Sci; 1982 Feb; 27(2):161-8. PubMed ID: 7075411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of ursodeoxycholic acid on biliary bile acid and bile lipid composition in gallstone patients.
    Stiehl A; Raedsch R; Rudolph G; Walker S
    Hepatology; 1984; 4(1):107-11. PubMed ID: 6693062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose ursodeoxycholic acid prolongs cholesterol nucleation time in gallbladder bile of patients with cholesterol gallstones.
    Jüngst D; Brenner G; Pratschke E; Paumgartner G
    J Hepatol; 1989 Jan; 8(1):1-6. PubMed ID: 2921499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different effects of chenodeoxycholic acid and ursodeoxycholic acid on serum lipoprotein concentrations in patients with radiolucent gallstones.
    Leiss O; von Bergmann K
    Scand J Gastroenterol; 1982 Aug; 17(5):587-92. PubMed ID: 7178821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A combination of chenodeoxycholic acid and ursodeoxycholic acid is more effective than either alone in reducing biliary cholesterol saturation.
    Podda M; Zuin M; Dioguardi ML; Festorazzi S; Dioguardi N
    Hepatology; 1982; 2(3):334-9. PubMed ID: 7076116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical treatment of biliary duct stones: effect of ursodeoxycholic acid administration.
    Salvioli G; Salati R; Lugli R; Zanni C
    Gut; 1983 Jul; 24(7):609-14. PubMed ID: 6345281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of ursodeoxycholic acid and aspirin on the formation of lithogenic bile and gallstones during loss of weight.
    Broomfield PH; Chopra R; Sheinbaum RC; Bonorris GG; Silverman A; Schoenfield LJ; Marks JW
    N Engl J Med; 1988 Dec; 319(24):1567-72. PubMed ID: 3200265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of ursodeoxycholic acid on biliary lipid coupling and on cholesterol absorption during fasting and eating in subjects with cholesterol gallstones.
    Lanzini A; Northfield TC
    Gastroenterology; 1988 Aug; 95(2):408-16. PubMed ID: 3391368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ursodeoxycholic acid therapy and biliary lipids--a dose-response study.
    Bateson MC; Ross PE; Murison J; Saunders JH; Bouchier IA
    Gut; 1980 Apr; 21(4):305-10. PubMed ID: 7429292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gallstone dissolution after 6 months of ursodeoxycholic acid (UDCA): effectiveness of different doses.
    Podda M; Zuin M; Carulli N; Ponz de Leon M; Dioguardi ML
    J Int Med Res; 1982; 10(1):59-63. PubMed ID: 7060825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of diet on bile acid kinetics and biliary lipid secretion in gallstone patients treated with ursodeoxycholic acid.
    Frenkiel PG; Lee DW; Cohen H; Gilmore CJ; Resser K; Bonorris GG; Marks JW; Schoenfield LJ
    Am J Clin Nutr; 1986 Feb; 43(2):239-50. PubMed ID: 3004189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ursodeoxycholic acid: a safe and effective agent for dissolving cholesterol gallstones.
    Tint GS; Salen G; Colalillo A; Graber D; Verga D; Speck J; Shefer S
    Ann Intern Med; 1982 Sep; 97(3):351-6. PubMed ID: 7051912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ursodeoxycholic acid: a review of its pharmacological properties and therapeutic efficacy.
    Ward A; Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1984 Feb; 27(2):95-131. PubMed ID: 6365507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in the effects of chenodeoxycholic and ursodeoxycholic acid on biliary lipid secretion and bile acid synthesis in patients with gallstones.
    von Bergmann K; Epple-Gutsfeld M; Leiss O
    Gastroenterology; 1984 Jul; 87(1):136-43. PubMed ID: 6724256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of ursodeoxycholic acid on bile supersaturated with cholesterol in patients pretreated with clofibrate.
    Kutz K; Schulte A
    Z Gastroenterol; 1981 May; 19(5):231-6. PubMed ID: 7257479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lovastatin added to ursodeoxycholic acid further reduces biliary cholesterol saturation.
    Logan GM; Duane WC
    Gastroenterology; 1990 Jun; 98(6):1572-6. PubMed ID: 2338194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.